FDA Inspection 1193508 — American National Red Cross, Penn Jersey Region
The FDA completed an inspection of American National Red Cross, Penn Jersey Region on December 2, 2022 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 2, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Philadelphia, PA (United States)